The Texas Workers' Compensation Research and Evaluation Group is proposing to investigate the impact on pharmacy costs and visits following the introduction of federal restrictions on the prescribing and dispensing of strong pain-relieving drugs.
The research group, part of the Department of Insurance, published its proposed research agenda on Tuesday.
Among the proposed studies is the impact of new federal guidelines on hydrocodone combination drugs, which last year were reclassified as Schedule 2 controlled substances and subject to a ban on automatic refills. If the proposed agen...
Comments